{"id":"https://openalex.org/W2147784083","doi":"https://doi.org/10.1097/01.alc.0000139823.30096.52","title":"A Pilot Evaluation of the Safety and Tolerability of Repeat Dose Administration of Long\u2010Acting Injectable Naltrexone (Vivitrex\u00ae) in Patients With Alcohol Dependence","display_name":"A Pilot Evaluation of the Safety and Tolerability of Repeat Dose Administration of Long\u2010Acting Injectable Naltrexone (Vivitrex\u00ae) in Patients With Alcohol Dependence","alternate_titles":[],"publication_year":2004,"publication_date":"2004-09-01","ids":{"openalex":"https://openalex.org/W2147784083","doi":"https://doi.org/10.1097/01.alc.0000139823.30096.52","mag":"2147784083","pmid":"https://pubmed.ncbi.nlm.nih.gov/15365306"},"language":"en","primary_location":{"id":"doi:10.1097/01.alc.0000139823.30096.52","doi":"https://doi.org/10.1097/01.alc.0000139823.30096.52","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.alc.0000139823.30096.52","pdf_url":null,"source":{"id":"https://openalex.org/S115510430","display_name":"Alcoholism Clinical and Experimental Research","issn_l":"0145-6008","issn":["0145-6008","1530-0277","2993-7175"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alcoholism: Clinical and Experimental Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2147784083"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032742542","display_name":"Bankole A. Johnson","orcid":"https://orcid.org/0000-0002-8901-6177","observed_orcids":["https://orcid.org/0000-0002-8901-6177"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Bankole A. Johnson","raw_affiliation_strings":["University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900, USA. bjohnson@uthscsa.edu","University of Texas Health Science Center at San Antonio, San Antonio, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900, USA. bjohnson@uthscsa.edu","institution_ids":["https://openalex.org/I165951966"]},{"raw_affiliation_string":"University of Texas Health Science Center at San Antonio, San Antonio, Texas","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113598041","display_name":"Nassima Ait\u2010Daoud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nassima Ait\u2010Daoud","raw_affiliation_strings":["University of Texas Health Science Center at San Antonio, San Antonio, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Health Science Center at San Antonio, San Antonio, Texas","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015738377","display_name":"Henri\u2010Jean Aubin","orcid":"https://orcid.org/0000-0002-6604-6672","observed_orcids":["https://orcid.org/0000-0002-6604-6672"]},"institutions":[{"id":"https://openalex.org/I4210111261","display_name":"H\u00f4pital \u00c9mile-Roux","ror":"https://ror.org/01sr2h546","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210111261","https://openalex.org/I4210130325"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henri\u2010Jean Aubin","raw_affiliation_strings":["Alcohol Treatment Center, Emile Roux Hospital, Limeil-Bre\u0301vannes, France","Alcohol Treatment Center, Emile Roux Hospital, Limeil-Br\u00e9vannes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcohol Treatment Center, Emile Roux Hospital, Limeil-Bre\u0301vannes, France","institution_ids":["https://openalex.org/I4210111261"]},{"raw_affiliation_string":"Alcohol Treatment Center, Emile Roux Hospital, Limeil-Br\u00e9vannes, France","institution_ids":["https://openalex.org/I4210111261"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071695786","display_name":"Wim van den Brink","orcid":"https://orcid.org/0000-0001-8301-0121","observed_orcids":["https://orcid.org/0000-0001-8301-0121"]},"institutions":[{"id":"https://openalex.org/I4210109446","display_name":"Amsterdam Institute for Addiction Research","ror":"https://ror.org/022gvqh28","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210109446","https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wim van den Brink","raw_affiliation_strings":["Amsterdam Institute of Addiction Research, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam Institute of Addiction Research, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210109446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055364737","display_name":"Richard V. Guzzetta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Guzzetta","raw_affiliation_strings":["Touchstone Medical Group, Clovis, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Touchstone Medical Group, Clovis, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085847229","display_name":"John W. Loewy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116259","display_name":"Alkermes (United States)","ror":"https://ror.org/038hqfn26","country_code":"US","type":"company","lineage":["https://openalex.org/I1328445063","https://openalex.org/I4210116259"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Loewy","raw_affiliation_strings":["Alkermes, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkermes, Inc., Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210116259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059074091","display_name":"Bernard L. Silverman","orcid":"https://orcid.org/0000-0002-5833-0147","observed_orcids":["https://orcid.org/0000-0002-5833-0147"]},"institutions":[{"id":"https://openalex.org/I4210116259","display_name":"Alkermes (United States)","ror":"https://ror.org/038hqfn26","country_code":"US","type":"company","lineage":["https://openalex.org/I1328445063","https://openalex.org/I4210116259"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bernard Silverman","raw_affiliation_strings":["Alkermes, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkermes, Inc., Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210116259"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017722417","display_name":"Elliot W. Ehrich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116259","display_name":"Alkermes (United States)","ror":"https://ror.org/038hqfn26","country_code":"US","type":"company","lineage":["https://openalex.org/I1328445063","https://openalex.org/I4210116259"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elliot Ehrich","raw_affiliation_strings":["Alkermes, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkermes, Inc., Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210116259"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5032742542"],"corresponding_institution_ids":["https://openalex.org/I165951966"],"apc_list":{"value":4110,"currency":"USD","value_usd":4110},"apc_paid":null,"fwci":5.2248,"has_fulltext":false,"cited_by_count":86,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.95897544,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"28","issue":"9","first_page":"1356","last_page":"1361"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11207","display_name":"Alcohol Consumption and Health Effects","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12494","display_name":"Alcoholism and Thiamine Deficiency","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alcoholism","display_name":"alcoholism","score":0.996999979019165},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7379999756813049},{"id":"https://openalex.org/keywords/intramuscular-injection","display_name":"intramuscular injection","score":0.7170000076293945},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.7080000042915344},{"id":"https://openalex.org/keywords/patient-adherence","display_name":"patient adherence","score":0.6110000014305115},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8050000071525574},{"id":"https://openalex.org/keywords/alcohol-consumption","display_name":"alcohol consumption","score":0.41600000858306885},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.9265998601913452},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8961699604988098},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5573192834854126},{"id":"https://openalex.org/C2779436514","wikidata":"https://www.wikidata.org/wiki/Q4713263","display_name":"Alcohol dependence","level":3,"score":0.5359632968902588},{"id":"https://openalex.org/C2781066024","wikidata":"https://www.wikidata.org/wiki/Q156","display_name":"Alcohol","level":2,"score":0.5340254306793213},{"id":"https://openalex.org/C2780765947","wikidata":"https://www.wikidata.org/wiki/Q12033531","display_name":"Administration (probate law)","level":2,"score":0.522383987903595},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4712667465209961},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.34439051151275635},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2354438602924347},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2113591432571411},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.09631228446960449},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.09199658036231995},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.08808961510658264},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000437","descriptor_name":"Alcoholism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005767","descriptor_name":"Gastrointestinal Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/01.alc.0000139823.30096.52","doi":"https://doi.org/10.1097/01.alc.0000139823.30096.52","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.alc.0000139823.30096.52","pdf_url":null,"source":{"id":"https://openalex.org/S115510430","display_name":"Alcoholism Clinical and Experimental Research","issn_l":"0145-6008","issn":["0145-6008","1530-0277","2993-7175"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alcoholism: Clinical and Experimental Research","raw_type":"journal-article"},{"id":"pmid:15365306","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15365306","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alcoholism, clinical and experimental research","raw_type":"Clinical Trial"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/3f6661b2-90b0-4192-bc8b-55d661a11e73","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/3f6661b2-90b0-4192-bc8b-55d661a11e73","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Johnson, B A, Ait-Daoud, N, Aubin, H-J, van den Brink, W, Guzzetta, R, Loewy, J, Silverman, B & Ehrich, E 2004, 'A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence', Alcoholism, clinical and experimental research, vol. 28, no. 9, pp. 1356-1361. https://doi.org/10.1097/01.ALC.0000139823.30096.52","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/6c3ed4de-ec78-48bd-bd72-3caa3a18860f","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/a-pilot-evaluation-of-the-safety-and-tolerability-of-repeat-dose-administration-of-longacting-injectable-naltrexone-vivitrex-in-patients-with-alcohol-dependence(6c3ed4de-ec78-48bd-bd72-3caa3a18860f).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Alcoholism, clinical and experimental research, 28(9), 1356 - 1361. Wiley-Blackwell","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G4299115859","display_name":"SUSTAINED RELEASE NALTREXONE AS TRTMT FOR ALCM - SBIR I","funder_award_id":"n43aa001002-000","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G7436063430","display_name":null,"funder_award_id":"N43 AA01002","funder_id":"https://openalex.org/F4320337330","funder_display_name":"National Institute on Alcohol Abuse and Alcoholism"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337330","display_name":"National Institute on Alcohol Abuse and Alcoholism","ror":"https://ror.org/02jzrsm59"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1475474724","https://openalex.org/W1481126026","https://openalex.org/W1633081414","https://openalex.org/W1966130613","https://openalex.org/W1980637329","https://openalex.org/W1984819772","https://openalex.org/W1987988504","https://openalex.org/W1995927407","https://openalex.org/W2031172625","https://openalex.org/W2045341302","https://openalex.org/W2052360330","https://openalex.org/W2093559862","https://openalex.org/W2097434502","https://openalex.org/W2104538950","https://openalex.org/W2108258874","https://openalex.org/W2108740579","https://openalex.org/W2138742021","https://openalex.org/W2150715760","https://openalex.org/W2157113531","https://openalex.org/W2168373111","https://openalex.org/W2173220105"],"related_works":["https://openalex.org/W2034538711","https://openalex.org/W2076078537","https://openalex.org/W18657166","https://openalex.org/W1554927263","https://openalex.org/W2154290339","https://openalex.org/W2152347083","https://openalex.org/W4253533571","https://openalex.org/W1995098257","https://openalex.org/W1966070495"],"abstract_inverted_index":{"BACKGROUND:":[0],":":[1,57,149,213],"Oral":[2],"naltrexone":[3,29,45,81,95,140,151,203,239],"is":[4,20],"currently":[5],"used":[6],"as":[7],"part":[8],"of":[9,43,73,78,139,202,216,235,244],"a":[10,102,187,226],"treatment":[11,92,120,127,194,210,243],"regimen":[12],"for":[13,53,190,225],"alcohol-dependent":[14,85,245],"patients,":[15],"but":[16],"its":[17,142],"clinical":[18],"utility":[19,234],"hampered":[21],"by":[22,38],"poor":[23],"patient":[24,36],"adherence.":[25],"A":[26,58],"long-acting":[27,237],"injectable":[28,94,238],"formulation":[30,82,240],"(Vivitrex)":[31],"was":[32,65,121,152],"designed":[33],"to":[34,67,91,123,132,163,174,231],"facilitate":[35],"adherence":[37],"providing":[39],"an":[40],"extended":[41],"duration":[42],"therapeutic":[44,200],"over":[46,116],"1":[47],"month,":[48],"thereby":[49],"eliminating":[50],"the":[51,69,207,221,233,242],"need":[52],"daily":[54],"dosing.":[55],"METHODS:":[56],"multicenter,":[59],"randomized,":[60],"double-blind,":[61],"placebo-controlled":[62],"pilot":[63,218],"study":[64,219],"conducted":[66],"evaluate":[68],"safety":[70],"and":[71,109,135,141,155,165,183,223],"tolerability":[72],"intramuscular":[74],"repeat":[75],"dose":[76],"administration":[77],"this":[79,217,236],"extended-release":[80],"in":[83,125,192,241],"DSM-IV":[84],"patients.":[86,246],"Thirty":[87],"patients":[88,124,171,191],"were":[89,110,146,161,204],"randomized":[90],"with":[93],"(400":[96],"mg;":[97],"n":[98],"=":[99,107],"25)":[100],"or":[101],"matching":[103],"placebo":[104],"injection":[105],"(n":[106],"5)":[108],"dosed":[111],"once":[112],"every":[113],"28":[114],"days":[115],"4":[117],"months.":[118],"Psychosocial":[119],"offered":[122],"both":[126,193],"groups.":[128,195],"Outcome":[129],"measures":[130],"related":[131],"drinking":[133],"activity":[134],"trough":[136],"plasma":[137],"concentrations":[138],"primary":[143],"metabolite,":[144],"6-beta-naltrexol,":[145],"evaluated.":[147],"RESULTS:":[148],"Injectable":[150],"generally":[153],"safe":[154],"well":[156],"tolerated.":[157],"Reported":[158],"adverse":[159,175,180],"events":[160,181],"mild":[162],"moderate":[164],"resolved":[166],"without":[167],"intervention;":[168],"only":[169],"two":[170],"discontinued":[172],"due":[173],"events.":[176],"The":[177,214],"most":[178],"common":[179],"(nausea":[182],"headache)":[184],"occurred":[185],"at":[186],"similar":[188],"rate":[189],"Pharmacokinetic":[196],"analysis":[197],"confirmed":[198],"that":[199],"levels":[201],"delivered":[205],"throughout":[206],"four":[208],"1-month":[209],"cycles.":[211],"CONCLUSIONS:":[212],"results":[215],"provide":[220],"basis":[222],"methods":[224],"larger,":[227],"more":[228],"definitive":[229],"trial":[230],"determine":[232]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2147784083","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
